Have a feature idea you'd love to see implemented?
Let us know!
PHGE BiomX Inc
Price (delayed)
$0.9698
Market cap
$17.36M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5
Enterprise value
-$5.46M
BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria
Highlights
The equity has soared by 73% YoY
The quick ratio has surged by 70% year-on-year and by 9% since the previous quarter
BiomX's net income has shrunk by 179% YoY and by 45% QoQ
PHGE's EPS is down by 35% since the previous quarter
Key stats
What are the main financial stats of PHGE
Market
Valuations
Earnings
Shares outstanding
17.9M
Market cap
$17.36M
Enterprise value
-$5.46M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.25
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$33.26M
EBITDA
-$32.26M
Free cash flow
-$34.74M
Per share
Balance sheet
Liquidity
EPS
-$5
Free cash flow per share
-$4.98
Book value per share
$3.93
Revenue per share
$0
TBVPS
$9.83
Total assets
$68.62M
Total liabilities
$41.19M
Debt
$9.9M
Equity
$27.43M
Working capital
$27.78M
Debt to equity
0.36
Current ratio
4.8
Quick ratio
4.48
Net debt/EBITDA
0.71
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-67.6%
Return on equity
-483.5%
Return on invested capital
-131%
Return on capital employed
-54.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PHGE stock price
How has the BiomX stock price performed over time
Intraday
2.08%
1 week
0.2%
1 month
-14.18%
1 year
-70.61%
YTD
-65.36%
QTD
-4.92%
Financial performance
How have BiomX's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$29.58M
Net income
-$35.2M
Gross margin
N/A
Net margin
N/A
BiomX's net income has shrunk by 179% YoY and by 45% QoQ
PHGE's operating income is down by 21% YoY and by 14% QoQ
Growth
What is BiomX's growth rate over time
Valuation
What is BiomX stock price valuation
P/E
N/A
P/B
0.25
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PHGE's EPS is down by 35% since the previous quarter
The stock's P/B is 85% below its 5-year quarterly average of 1.6
The equity has soared by 73% YoY
Efficiency
How efficient is BiomX business performance
PHGE's return on invested capital has dropped by 143% year-on-year and by 13% since the previous quarter
The ROA has plunged by 141% YoY and by 26% from the previous quarter
The ROE is up by 13% since the previous quarter
Dividends
What is PHGE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PHGE.
Financial health
How did BiomX financials performed over time
The total assets is 67% greater than the total liabilities
The quick ratio has surged by 70% year-on-year and by 9% since the previous quarter
BiomX's current ratio has surged by 69% YoY and by 9% QoQ
BiomX's debt is 64% less than its equity
The company's debt to equity has surged by 134% QoQ but it has shrunk by 68% YoY
The equity has soared by 73% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.